ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 64 filers reported holding ONCOCYTE CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,073 | +10.4% | 62,284 | 0.0% | 0.00% | – |
| Q4 2022 | $19,987 | -56.6% | 62,284 | 0.0% | 0.00% | – |
| Q3 2022 | $46,000 | -19.3% | 62,284 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | -76.2% | 62,284 | -61.1% | 0.00% | – |
| Q1 2022 | $239,000 | -31.3% | 160,186 | 0.0% | 0.00% | – |
| Q4 2021 | $348,000 | -39.1% | 160,186 | 0.0% | 0.00% | – |
| Q3 2021 | $571,000 | -45.0% | 160,186 | -11.4% | 0.00% | – |
| Q2 2021 | $1,038,000 | +9.5% | 180,815 | -0.9% | 0.00% | – |
| Q1 2021 | $948,000 | +146.2% | 182,544 | +13.5% | 0.00% | – |
| Q4 2020 | $385,000 | +97.4% | 160,882 | +15.2% | 0.00% | – |
| Q3 2020 | $195,000 | -0.5% | 139,678 | +36.1% | 0.00% | – |
| Q2 2020 | $196,000 | +47.4% | 102,611 | +89.8% | 0.00% | – |
| Q1 2020 | $133,000 | +9.0% | 54,072 | 0.0% | 0.00% | – |
| Q4 2019 | $122,000 | +7.0% | 54,072 | 0.0% | 0.00% | – |
| Q3 2019 | $114,000 | -21.4% | 54,072 | -6.7% | 0.00% | – |
| Q2 2019 | $145,000 | +173.6% | 57,938 | +337.2% | 0.00% | – |
| Q1 2019 | $53,000 | – | 13,252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
| Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
| Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
| Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
| AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
| Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
| CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
| Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |